Johnson & Johnson Vaccine’s US future depends on cautious ACIP experts
Advisors from the Centers for Disease Control and Prevention are under pressure to decide whether the US can resume the use of Johnson & Johnson’s Covid-19 vaccine, perhaps with some res…
